Framingham Risk Score for Prediction of Cardiovascular Diseases: A Population-Based Study from Southern Europe

• Luis M. Artigao-Rodenas,

  Affiliation Community Medicine, Zone 3 Primary Health Care Centre, Albacete, Spain

  ⨯
• Julio A. Carbayo-Herencia,

  Affiliations Medical Corps, Academia General del Aire, Murcia, Spain, School of Medicine, University of Castilla-La Mancha, Albacete, Spain

  ⨯
• Juan A. Divisón-Garrote,

  Affiliation Community Medicine, Zone 2 Primary Health Care Centre, Albacete, Spain

  ⨯
• Vicente F. Gil-Guillén ,

  * E-mail: vte.gil@gmail.com

  Affiliations Clinical Medicine Department, Chair of Family, University of Miguel Hernandez, San Juan de Alicante, Spain, Research Unit, Elda Hospital, Elda, Spain

  ⨯
• Javier Massó-Orozco,

  Affiliation Community Medicine, Casas de Juan Núñez Primary Health Care Centre, Albacete, Spain

  ⨯
• Marta Simarro-Rueda,

  Affiliation Community Medicine, Zone 4 Primary Health Care Centre, Albacete, Spain

  ⨯
• Francisca Molina-Escribano,

  Affiliation Community Medicine, Casas Ibáñez Primary Health Care Centre, Albacete, Spain

  ⨯
• Carlos Sanchis,

  Affiliation Community Medicine, Primary Health Care Centre, Valencia, Spain

  ⨯
• Lucinio Carrión-Valero,

  Affiliation Community Medicine, Zone 2 Primary Health Care Centre, Albacete, Spain

  ⨯
• Enrique López de Coca,

  Affiliation Internal Medicine, Primary Health Care Centre, Albacete, Spain

  ⨯
• David Caldevilla,

  Affiliation Universitary Hospitalary Complex, Albacete, Spain

  ⨯
• Juan López-Abril,

  Affiliation Community Medicine, Zone 3 Primary Health Care Centre, Albacete, Spain

  ⨯
• Concepción Carratalá-Munuera,

  Affiliation Clinical Medicine Department, Chair of Family, University of Miguel Hernandez, San Juan de Alicante, Spain

  ⨯
• Adriana Lopez-Pineda,

  Affiliation Clinical Medicine Department, Chair of Family, University of Miguel Hernandez, San Juan de Alicante, Spain

  ⨯
• on behalf of the Grupo de Enfermedades Vasculares de Albacete (GEVA)¶

  ¶Membership of the Grupo de Enfermedades Vasculares de Albacete (GEVA) is provided in the Acknowledgments

  ⨯